218 related articles for article (PubMed ID: 9573578)
1. Hemodynamic support and the role of dopamine.
Bellomo R; Cole L; Ronco C
Kidney Int Suppl; 1998 May; 66():S71-4. PubMed ID: 9573578
[TBL] [Abstract][Full Text] [Related]
2. Use of inotropes in the critical care setting.
Löllgen H; Drexler H
Crit Care Med; 1990 Jan; 18(1 Pt 2):S56-60. PubMed ID: 2136722
[TBL] [Abstract][Full Text] [Related]
3. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
El Mokhtari NE; Arlt A; Meissner A; Lins M
Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265
[TBL] [Abstract][Full Text] [Related]
4. Vassopressors and inotropes.
Med Lett Drugs Ther; 2011 Nov; 53(1377):90-2. PubMed ID: 22075670
[No Abstract] [Full Text] [Related]
5. Inotrope and vasopressor therapy of septic shock.
Hollenberg SM
Crit Care Clin; 2009 Oct; 25(4):781-802, ix. PubMed ID: 19892253
[TBL] [Abstract][Full Text] [Related]
6. Current practice of hemodynamic monitoring and vasopressor and inotropic therapy in post-operative cardiac surgery patients in Germany: results from a postal survey.
Kastrup M; Markewitz A; Spies C; Carl M; Erb J; Grosse J; Schirmer U
Acta Anaesthesiol Scand; 2007 Mar; 51(3):347-58. PubMed ID: 17096667
[TBL] [Abstract][Full Text] [Related]
7. Inotrope and vasopressor therapy of septic shock.
Hollenberg SM
Crit Care Nurs Clin North Am; 2011 Mar; 23(1):127-48. PubMed ID: 21316572
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for the treatment of patients with septic shock.
Meier-Hellmann A; Reinhart K
Acta Anaesthesiol Scand Suppl; 1997; 111():177-80. PubMed ID: 9421002
[No Abstract] [Full Text] [Related]
9. [Hemodynamic effects of amrinone, dobutamine and dopamine in the cardiac low output syndrome following open-heart surgery].
Husedzinović I; Rumboldt Z; Ivancan V; Nikić N; Rudeź I; Biocina B; Sutlić Z
Lijec Vjesn; 1995 Jun; 117 Suppl 2():32-4. PubMed ID: 8649147
[TBL] [Abstract][Full Text] [Related]
10. Inotropic agents in the treatment of cardiogenic shock.
Bourdarias JP; Dubourg O; Gueret P; Ferrier A; Bardet J
Pharmacol Ther; 1983; 22(1):53-79. PubMed ID: 6361798
[No Abstract] [Full Text] [Related]
11. Acute renal failure secondary to milrinone in a patient with cardiac amyloidosis.
Saab G; Mindel G; Ewald G; Vijayan A
Am J Kidney Dis; 2002 Aug; 40(2):E7. PubMed ID: 12148128
[TBL] [Abstract][Full Text] [Related]
12. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study.
Levy B; Perez P; Perny J; Thivilier C; Gerard A
Crit Care Med; 2011 Mar; 39(3):450-5. PubMed ID: 21037469
[TBL] [Abstract][Full Text] [Related]
13. Treatment for paediatric low cardiac output syndrome: results from the European EuLoCOS-Paed survey.
Vogt W; Läer S
Arch Dis Child; 2011 Dec; 96(12):1180-6. PubMed ID: 22034494
[TBL] [Abstract][Full Text] [Related]
14. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
[TBL] [Abstract][Full Text] [Related]
15. General overview and update of positive inotropic therapy.
Leier CV
Am J Med; 1986 Oct; 81(4C):40-5. PubMed ID: 2946223
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular pharmacotherapy update for the intensive care unit.
Coons JC; Seidl E
Crit Care Nurs Q; 2007; 30(1):44-57. PubMed ID: 17198036
[TBL] [Abstract][Full Text] [Related]
17. [Inotropic and vasopressive drugs during anesthesia and critical care. Current data].
Blanloeil Y; Videcoq M; Train M; Le Marec H
Agressologie; 1991; 32(1):23-33. PubMed ID: 2063978
[TBL] [Abstract][Full Text] [Related]
18. [Postoperative cardiac care: theoretical use of various cardiovascular agents].
Sakamoto T; Suzuki A
Rinsho Kyobu Geka; 1985; 5(2):263-70. PubMed ID: 9423013
[No Abstract] [Full Text] [Related]
19. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive drugs and acute kidney injury.
Bellomo R; Wan L; May C
Crit Care Med; 2008 Apr; 36(4 Suppl):S179-86. PubMed ID: 18382191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
